FDA — authorised 9 November 2020
- Marketing authorisation holder: Eli Lilly and Company
- Status: approved
🇺🇸 Ly-Cov016 in United States
FDA authorised Ly-Cov016 on 9 November 2020
Marketing authorisation
Ly-Cov016 in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Infectious Disease approved in United States
Frequently asked questions
Is Ly-Cov016 approved in United States?
Yes. FDA authorised it on 9 November 2020.
Who is the marketing authorisation holder for Ly-Cov016 in United States?
Eli Lilly and Company holds the US marketing authorisation.